Decibel, Regeneron enter hearing loss collaboration

Decibel Therapeutics Inc. (Boston, Mass.) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) began a collaboration to discover and develop hearing loss and tinnitus therapies for up to seven years.

Read the full 277 word article

User Sign In